Yongin-si

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Colorectal cancer1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Type 2 diabetes1 trial

Phase

• Phase 21 trial

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• AstraZeneca3 trials

Running trials

• Active, not recruiting

  A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

  NCT06792695· Phase 2· AstraZeneca· Source

Closed trials

• Completed

  QTERN (SAXAGLIPTIN/DAPAGLIFLOZIN FDC) Regulatory Post-Marketing Surveillance

  NCT05160974· AstraZeneca· Source

• Completed

  Open Label, Multicenter, Real World Practice of Durvalumab (Imfinzi PMS)

  NCT04068168· AstraZeneca· Source